Vija Riekstiņa
Vija Riekstiņa publishes mostly in Infectious Diseases, Epidemiology and Surgery, on topics such as Tuberculosis Research and Epidemiology, Pneumonia and Respiratory Infections and Pneumocystis jirovecii pneumonia detection and treatment.
- World rank
- #535,844 of 7,710,434 ranked researchers
- Rank in Latvia
- #32 of 4,070
- Works
- 50
- Citations
- 3.5k
- Citations per work
- 70.4
What does Vija Riekstiņa research?
Vija Riekstiņa's work is mostly in Medicine (79%), Pharmacology, Toxicology and Pharmaceutics (3%), Biochemistry, Genetics and Molecular Biology (2%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences4079.3%
- Medicine4079.3%
- Everything else714.0%
- Life Sciences25.0%
- Physical Sciences11.7%
- Engineering11.7%
- 1Infectious Diseases40% of their works
- 2Epidemiology26% of their works
- 3Surgery14% of their works
- 4Pharmacology3% of their works
- 5Control and Systems Engineering2% of their works
- 6Molecular Biology2% of their works
Research topics
- Tuberculosis Research and Epidemiology
- Pneumonia and Respiratory Infections
- Pneumocystis jirovecii pneumonia detection and treatment
- Diagnosis and treatment of tuberculosis
- Infectious Diseases and Tuberculosis
- Mycobacterium research and diagnosis
- Drug-Induced Hepatotoxicity and Protection
- HIV/AIDS Research and Interventions
Which keywords describe Vija Riekstiņa's research?
The keywords of their largest research topics: Epidemiology, Diagnosis, Treatment, Mycobacterium tuberculosis, Tuberculosis, Clinical Practice Guidelines, Antiretroviral Therapy and Community-Acquired Pneumonia.
- Hepatotoxicity
- Drug-Induced Liver Injury
- Mycobacterium avium
- Spinal Epidural Abscess
- Pneumocystis
- Abdominal Tuberculosis
- Community-Acquired Pneumonia
- Clinical Practice Guidelines
- Mycobacterium tuberculosis
- Diagnosis
- Epidemiology
- Treatment
- Tuberculosis
- Antiretroviral Therapy
- Pneumococcal Conjugate Vaccine
- Diagnostic Challenges
- Pneumonia
- Tuberculous Meningitis
- Nontuberculous Mycobacteria
- HIV Transmission
- Preexposure Prophylaxis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Epidemiology734 topics
- Diagnosis593 topics
- Treatment593 topics
- Mycobacterium tuberculosis441 topic
- Tuberculosis441 topic
- Clinical Practice Guidelines222 topics
- Antiretroviral Therapy203 topics
- Community-Acquired Pneumonia141 topic
- Pneumococcal Conjugate Vaccine141 topic
- Abdominal Tuberculosis91 topic
- Diagnostic Challenges91 topic
- Pneumocystis91 topic
- Pneumonia91 topic
- Spinal Epidural Abscess81 topic
- Tuberculous Meningitis81 topic
- Mycobacterium avium61 topic
- Nontuberculous Mycobacteria61 topic
- Drug-Induced Liver Injury31 topic
- HIV Transmission31 topic
- Hepatotoxicity31 topic
- Preexposure Prophylaxis31 topic
Where does Vija Riekstiņa work?
Vija Riekstiņa's main affiliation in the publication record is Riga East University Hospital, Latvia.
How many publications and citations does Vija Riekstiņa have?
OpenAlex counts 50 works and 3,518 citations for Vija Riekstiņa, an h-index of 24, ranking #535,844 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Vija Riekstiņa. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.